COUR vs MRNA · rev $494.3M vs rev $145.0M
Coursera Inc (COUR) versus Moderna Inc (MRNA) — a side-by-side from cached financials, not a winner call.
Coursera Inc (COUR) is a education & training services company listed on US.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stephane Bancel.
Latest reported COUR revenue for 2026-06-30 was $494.3M. Net income was -$100.9M. COUR currently screens at market cap $1.35B.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
COUR currently screens at market cap $1.35B. MRNA currently screens at market cap $24.52B.
Not investment advice. Open the COUR and MRNA stock pages for the full models.
Not investment advice.